MedPath

Efficacy of Novel Blue Silver Nanoparticles Hydrogel versus Reference Hydrogel: A Prospective Randomized Controlled Trial for Acute and Chronic Wound Management

Phase 4
Completed
Conditions
Patients who have acute or chronic partial- or full- thickness wounds and wounds due to thermal burns and accidental injury were included.
Acute or chronic wounds
Partial or full thickness wound
Registration Number
TCTR20230623001
Lead Sponsor
ovatec Healthcare Co.,Ltd.
Brief Summary

The blue AgNPs and reference hydrogels were comparable in terms of wound area reduction and pain scores during the changing of wound dressings, with no significant differences. Patients in the blue AgNPs hydrogel group showed low rates of bacterial infection for both gram-negative and gram-positive strains; in particular, there was almost complete prevention of infection by gram-positive strains at day 21 after treatment initiation.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
62
Inclusion Criteria

1. All participants were required to be more than 10 years of age and have acute or chronic partial- or full-thickness wounds
2. wounds due to thermal burns and accidental injury were included.

Exclusion Criteria

1. Patients were pregnant, allergic to hydrogel or silver.
2. Patients had a compromised immune system, or had any other connective tissue disease.
3. Infected wounds with frank pus or necrotic tissues were also excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
wound area reduction (wound healing) on days 0, 7, 14, and 21 after treatment initiation % wound area reduction
Secondary Outcome Measures
NameTimeMethod
pain intensity on days 0, 7, 14, and 21 after treatment initiation 10-point visual analogue scale score,infection prevention at day 0, 7, 14, and 21 after treatment initiation wound swab culture
© Copyright 2025. All Rights Reserved by MedPath